nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up
|
Krawtchenko, N. |
|
2007 |
|
s2 |
p. 34-40 |
artikel |
2 |
Efalizumab in routine use: a clinical experience
|
Selenko-Gebauer, N. |
|
2007 |
|
s2 |
p. 1-6 |
artikel |
3 |
Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark
|
Kragballe, Knud |
|
2007 |
|
s2 |
p. 7-11 |
artikel |
4 |
Epidemiology and aetiology of basal cell carcinoma
|
Roewert-Huber, J. |
|
2007 |
|
s2 |
p. 47-51 |
artikel |
5 |
Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies
|
Schöfer, H. |
|
2007 |
|
s2 |
p. 52-55 |
artikel |
6 |
Foreword
|
S tingl, G eorg |
|
2007 |
|
s2 |
p. iii |
artikel |
7 |
Imiquimod: mode of action
|
Schön, M.P |
|
2007 |
|
s2 |
p. 8-13 |
artikel |
8 |
Imiquimod treatment of papilloma virus and DMBA /TPA-induced cutaneous skin cancer in Mastomys coucha: an unique animal model system useful for preclinical studies
|
Nafz, J. |
|
2007 |
|
s2 |
p. 14-17 |
artikel |
9 |
Immune response profiles in human skin
|
Meyer, T. |
|
2007 |
|
s2 |
p. 1-7 |
artikel |
10 |
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience
|
Costanzo, A. |
|
2007 |
|
s2 |
p. 17-23 |
artikel |
11 |
Management of field change in actinic keratosis
|
Vatve, M. |
|
2007 |
|
s2 |
p. 21-24 |
artikel |
12 |
Managing moderate-to-severe psoriasis with efalizumab: experience at a single Spanish institute
|
Ferrándiz, C. |
|
2007 |
|
s2 |
p. 24-29 |
artikel |
13 |
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head
|
Stockfleth, E. |
|
2007 |
|
s2 |
p. 41-46 |
artikel |
14 |
Noninvasive diagnostic tools for nonmelanoma skin cancer
|
Ulrich, M. |
|
2007 |
|
s2 |
p. 56-58 |
artikel |
15 |
Pathology and pathobiology of actinic (solar) keratosis – an update
|
Roewert-Huber, J. |
|
2007 |
|
s2 |
p. 18-20 |
artikel |
16 |
The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital
|
Antoniou, C. |
|
2007 |
|
s2 |
p. 12-16 |
artikel |
17 |
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients
|
Ulrich, C. |
|
2007 |
|
s2 |
p. 25-31 |
artikel |
18 |
Update on actinic keratosis in clinical trial experience with imiquimod
|
F errándiz, C. |
|
2007 |
|
s2 |
p. 32-33 |
artikel |